Pharmaceutical agents, typically synthetic or desiccated forms of thyroid hormones (levothyroxine, liothyronine, or combinations thereof), prescribed to treat thyroid dysfunction, most commonly hypothyroidism. These medications are administered to restore euthyroidism, the state of normal thyroid hormone levels, thereby regulating metabolism, energy expenditure, and numerous systemic functions. Precise dosing is crucial for managing the complex interplay of the hypothalamic-pituitary-thyroid axis.
Origin
The earliest forms of thyroid therapy involved desiccated animal thyroid gland extracts, dating back to the late 19th century. The subsequent isolation and synthesis of thyroxine (T4) and triiodothyronine (T3) in the 20th century led to more standardized pharmaceutical treatments. This medication category is fundamental to modern endocrinology.
Mechanism
The medication functions by directly replacing the deficient endogenous thyroid hormones. Levothyroxine (synthetic T4) is converted in the body to the active form, T3, which then binds to nuclear receptors in target cells throughout the body. This binding modulates gene expression, ultimately regulating basal metabolic rate, protein synthesis, and sensitivity to other hormones like catecholamines.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.